Total Payments
$3,885
2024 Payments
$399.10
Companies
30
Transactions
160
Medicare Patients
4,137
Medicare Billing
$279,728
Payment Breakdown by Category
Food & Beverage$3,785 (97.4%)
Education$99.99 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,785 | 159 | 97.4% |
| Education | $99.99 | 1 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $739.48 | 45 | $0 (2024) |
| Janssen Biotech, Inc. | $421.43 | 26 | $0 (2024) |
| Amgen Inc. | $390.88 | 14 | $0 (2024) |
| Incyte Corporation | $261.56 | 4 | $0 (2023) |
| DUSA Pharmaceuticals, Inc. | $244.36 | 3 | $0 (2019) |
| Lilly USA, LLC | $243.37 | 16 | $0 (2019) |
| Sun Pharmaceutical Industries Inc. | $238.08 | 6 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $194.28 | 8 | $0 (2024) |
| Almirall LLC | $149.41 | 1 | $0 (2021) |
| Genentech USA, Inc. | $139.40 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $399.10 | 20 | ABBVIE INC. ($133.25) |
| 2023 | $260.20 | 12 | ABBVIE INC. ($237.15) |
| 2022 | $448.22 | 11 | Incyte Corporation ($238.51) |
| 2021 | $149.41 | 1 | Almirall LLC ($149.41) |
| 2020 | $75.31 | 4 | Sun Pharmaceutical Industries Inc. ($22.71) |
| 2019 | $559.57 | 22 | Sun Pharmaceutical Industries Inc. ($215.37) |
| 2018 | $654.18 | 37 | Lilly USA, LLC ($120.62) |
| 2017 | $1,339 | 53 | Amgen Inc. ($297.84) |
All Payment Transactions
160 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.34 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.90 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Immunology | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.18 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.24 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: Immunology | ||||||
| 08/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.43 | General |
| Category: IMMUNOLOGY | ||||||
| 07/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.15 | General |
| Category: IMMUNOLOGY | ||||||
| 06/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: IMMUNOLOGY | ||||||
| 05/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.62 | General |
| Category: IMMUNOLOGY | ||||||
| 05/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.60 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.89 | General |
| Category: IMMUNOLOGY | ||||||
| 02/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 02/01/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: Inflammation | ||||||
| 12/19/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.69 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,112 | 1,833 | $176,552 | $76,607 |
| 2022 | 15 | 1,161 | 1,975 | $198,502 | $83,566 |
| 2021 | 12 | 968 | 1,568 | $154,712 | $68,676 |
| 2020 | 10 | 896 | 1,370 | $125,729 | $50,880 |
Total Patients
4,137
Total Services
6,746
Medicare Billing
$279,728
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 322 | 389 | $53,938 | $23,141 | 42.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 143 | 172 | $30,836 | $14,412 | 46.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 217 | 262 | $27,516 | $10,323 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 85 | $16,664 | $7,649 | 45.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 80 | 91 | $14,559 | $5,507 | 37.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 150 | 692 | $7,324 | $3,612 | 49.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 12 | 14 | $6,689 | $3,496 | 52.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 14 | 18 | $4,769 | $2,421 | 50.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $5,148 | $2,061 | 40.0% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 17 | 19 | $3,969 | $1,688 | 42.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 36 | 39 | $3,398 | $1,428 | 42.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 18 | 22 | $1,741 | $869.42 | 49.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 326 | 437 | $61,184 | $25,863 | 42.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 157 | 198 | $35,703 | $15,796 | 44.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 210 | 257 | $27,160 | $9,400 | 34.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 93 | 108 | $17,622 | $7,064 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 47 | $9,282 | $4,135 | 44.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 148 | 727 | $7,830 | $3,928 | 50.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 14 | 15 | $7,212 | $3,847 | 53.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 42 | 42 | $7,246 | $2,988 | 41.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 15 | 20 | $5,335 | $2,312 | 43.3% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 21 | 23 | $4,838 | $2,298 | 47.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 38 | 40 | $3,501 | $1,631 | 46.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 12 | 13 | $3,662 | $1,594 | 43.5% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 12 | 12 | $4,626 | $1,231 | 26.6% |
About Dr. Jeanne Osborn, M.D
Dr. Jeanne Osborn, M.D is a Dermatology healthcare provider based in Colorado Springs, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1013994367.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeanne Osborn, M.D has received a total of $3,885 in payments from pharmaceutical and medical device companies, with $399.10 received in 2024. These payments were reported across 160 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,785).
As a Medicare-enrolled provider, Osborn has provided services to 4,137 Medicare beneficiaries, totaling 6,746 services with total Medicare billing of $279,728. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Procedural Dermatology
- Location Colorado Springs, CO
- Active Since 12/28/2005
- Last Updated 10/21/2015
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1013994367
Products in Payments
- RINVOQ (Biological) $518.88
- OPZELURA (Drug) $261.56
- Enbrel (Biological) $255.67
- TALTZ (Drug) $243.37
- Levulan (Drug) $199.34
- Humira (Biological) $195.70
- Tremfya (Drug) $194.23
- DUPIXENT (Biological) $192.85
- DUPIXENT (Drug) $166.35
- Klisyri (Drug) $149.41
- TREMFYA (Drug) $142.08
- STELARA (Biological) $135.62
- Erivedge (Biological) $125.71
- ODOMZO (Drug) $119.55
- ILUMYA (Biological) $118.53
- COSENTYX (Biological) $82.23
- REMICADE (Biological) $65.85
- DUPIXENT DUPILUMAB INJECTION (Biological) $62.66
- ENSTILAR (Drug) $46.74
- Cimzia (Drug) $46.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Colorado Springs
Dr. Victoria Moss, M.d, M.D
Dermatology — Payments: $555,426
Dermatology $555,426
Brian Sperber, M.d., Ph.d, M.D., PH.D
Dermatology — Payments: $13,810
Dermatology $13,810
Dr. Vinh Chung, Md, Mth, Mpharmsci, MD, MTH, MPHARMSCI
Dermatology — Payments: $10,231
Dermatology $10,231
Dr. Kathleen Elmer, M.d, M.D
Dermatology — Payments: $9,997
Dermatology $9,997
Nathan Trookman, M.d, M.D
Dermatology — Payments: $8,556
Dermatology $8,556
Dr. Elizabeth Piantanida, Md, MD
Dermatology — Payments: $7,956
Dermatology $7,956